EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression

Alexandra Monceau, Rasya Gokul Nath, Xavier Suárez-Calvet, Olimpia Musumeci, Antonio Toscano, Biruta Kierdaszuk, Anna Kostera-Pruszczyk, Cristina Domínguez-González iD, Aurelio Hernández-Lain iD, Carmen Paradas iD, Eloy Rivas, George Papadimas und 23 weitere

Brain · 03.12.2024 · 147 (12) · 4213-4226

DOI: 10.1093/brain/awae249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 24.07.2024. Verfasst von Alexandra Monceau und 34 weiteren Autor:innen. Beteiligte Einrichtung: The John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle Upon Tyne NHS Trust…. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Transcriptome, Disease Progression, Muscle, Skeletal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Academy of Medical Sciences Professorship Scheme, Medical Research Council, Fundación Isabel Gemio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Late-onset Pompe disease (LOPD) is a rare genetic disorder caused by the deficiency of acid alpha-glucosidase leading to progressive cellular dysfunction owing to the accumulation of glycogen in the lysosome. The mechanism of relentless muscle damage (a classic manifestation of the disease) has been studied extensively by analysing the whole-muscle tissue; however, little, if anything, is known about transcriptional heterogeneity among nuclei within the multinucleated skeletal muscle cells. This is the first report of application of single-nucleus RNA sequencing to uncover changes in the gene expression profile in muscle biopsies from eight patients with LOPD and four muscle samples from age- and sex-matched healthy controls. We matched these changes with histological findings using GeoMx spatial transcriptomics to compare the transcriptome of control myofibres from healthy individuals with non-vacuolated (histologically unaffected) and vacuolated (histologically affected) myofibres of LODP patients. We observed an increase in the proportion of slow and regenerative muscle fibres and macrophages in LOPD muscles. The expression of the genes involved in glycolysis was reduced, whereas the expression of the genes involved in the metabolism of lipids and amino acids was increased in non-vacuolated fibres, indicating early metabolic abnormalities. Additionally, we detected upregulation of autophagy genes and downregulation of the genes involved in ribosomal and mitochondrial function leading to defective oxidative phosphorylation. Upregulation of genes associated with inflammation, apoptosis and muscle regeneration was observed only in vacuolated fibres. Notably, enzyme replacement therapy (the only available therapy for the disease) showed a tendency to restore dysregulated metabolism, particularly within slow fibres. A combination of single-nucleus RNA sequencing and spatial transcriptomics revealed the landscape of the normal and diseased muscle and highlighted the early abnormalities associated with disease progression. Thus, the application of these two new cutting-edge technologies provided insight into the molecular pathophysiology of muscle damage in LOPD and identified potential avenues for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IITranscriptomeDisease ProgressionMuscle, SkeletalHumansMaleFemaleAdultMiddle AgedAgedAge of OnsetBiomarkers

Stichwörter der Autor:innen

glycogen storage diseasemetabolismmitochondria abnormality

Substanzen

Biomarkers

Autor:innen und Institutionen

  • The John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle Upon Tyne NHS Trust, Newcastle Upon Tyne, NE13BZ, UK.
  • Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Neuromuscular Disease Unit, 08041 Barcelona, Spain.
  • Unit of Neurology and Neuromuscular Diseases, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
  • Department of Neurology, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Neurology, Neuromuscular Unit, Instituto de Investigación imas12, Hospital 12 de Octubre, 28041 Madrid, Spain.
  • Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Cristina Domínguez-González, Aurelio Hernández-Lain, Carmen Paradas, James Lilleker, Holger Heyn, Amy Vincent

Förderung

  • Academy of Medical Sciences Professorship Scheme
  • Medical Research Council
  • Fundación Isabel Gemio
  • Spark Therapeutics

Zitieren

APA

Monceau, A., Nath, R. G., Suárez-Calvet, X., Musumeci, O., Toscano, A., Kierdaszuk, B., Kostera-Pruszczyk, A., Domínguez-González, C., Hernández-Lain, A., Paradas, C., Rivas, E., Papadimas, G., Papadopoulos, C., Chrysanthou-Piterou, M., Gallardo, E., Olivé, M., Lilleker, J., Roberts, M. E., Marchese, D., …, & Díaz-Manera, J. (2024). Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression. Brain, 147(12), 4213-4226. https://doi.org/10.1093/brain/awae249

Vancouver

Monceau A, Nath RG, Suárez-Calvet X, Musumeci O, Toscano A, Kierdaszuk B, et al. Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression. Brain. 2024;147(12):4213-4226. doi:10.1093/brain/awae249

BibTeX
@article{Monceau2024,
  author = {Monceau, Alexandra and Nath, Rasya Gokul and Suárez-Calvet, Xavier and Musumeci, Olimpia and Toscano, Antonio and Kierdaszuk, Biruta and Kostera-Pruszczyk, Anna and Domínguez-González, Cristina and Hernández-Lain, Aurelio and Paradas, Carmen and Rivas, Eloy and Papadimas, George and Papadopoulos, Constantinos and Chrysanthou-Piterou, Margarita and Gallardo, Eduard and Olivé, Montse and Lilleker, James and Roberts, Mark E and Marchese, Domenica and Lunazzi, Giulia and Heyn, Holger and Fernández-Simón, Esther and Villalobos, Elisa and Clark, James and Katsikis, Panos and Collins, Catherine and Mehra, Priyanka and Laidler, Zoe and Vincent, Amy and Tasca, Giorgio and Marini-Bettolo, Chiara and Guglieri, Michela and Straub, Volker and Raben, Nina and Díaz-Manera, Jordi},
  title = {Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {12},
  pages = {4213--4226},
  doi = {10.1093/brain/awae249}
}
Kostenlos starten →